Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $139.69 USD
Change Today +2.70 / 1.97%
Volume 140.2K
VRTX On Other Exchanges
Symbol
Exchange
Mexico
Frankfurt
As of 9:52 AM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Terrence C. Kearney

Independent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 32 board members in 3 different organizations across 5 different industries.

See Board Relationships
60$805,378

Background*

Mr. Terrence C. Kearney, also known as Terry, served as the Chief Operating Officer of Hospira Inc., from April 25, 2006 to January 4, 2011 and also served as its Senior Vice President of Finance and Chief Financial Officer from April 30, 2004 to 2006. Mr. Kearney served on the Executive Management Team for Hospira, Inc. from April 2004 to January 2011. He had broad responsibility for the global operations, including commercial, manufacturing and research and development ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

2011-Present
Independent Director, Chairman of Audit & Finance Committee and Member of Management Development & Compensation Committee
2014-Present
Director, Member of Compensation Committee and Member of Audit Committee
2014-Present
Director and Chairman of Audit Committee

Education*

BA
University of Illinois-Urbana-Champaign
Master's Degree
University of Denver
MBA
University of Denver

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options106,250
Unexercisable Options3,750
Total Number of Options110,000

Total Compensation*

Total Annual Cash Compensation$80,000
Total Calculated Compensation$805,378
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $139.65 USD +2.66

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$916.0K
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$1.0M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.